Trial Profile
Blood Ropivacaine Concentrations Following Unilateral Chest Wall Nerve Block and Continuous Infusion in Infants and Toddlers Undergoing Thoracotomies
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2023
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- 27 Nov 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 27 Nov 2023 Planned primary completion date changed from 1 Nov 2023 to 1 Dec 2024.
- 15 Nov 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.